Gretchen Vogel, Kai Kupferschmidt. Show Affiliations »
Abstract
Mesh: See more » Blood Coagulation Disorders/epidemiologyCOVID-19/prevention & controlCOVID-19 Vaccines/adverse effectsCOVID-19 Vaccines/immunologyClinical Trials, Phase III as TopicDrug IndustryEuropeHumansImmunization ProgramsImmunogenicity, VaccineUnited States
Substances: See more » COVID-19 VaccinesChAdOx1 COVID-19 vaccine
Year: 2021 PMID: 33766863 DOI: 10.1126/science.371.6536.1294
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728